tirzepatide vial 2.5mg Mounjaro® 5mg – Injection – FILLERFY Tirzepatide Instructions | Allure Medical
Description
The mean percent weight change from week 36 to week 88 was 5.5% with tirzepatide vs 14.0% with placebo (difference, 19.4% [95% CI, 21.2% to 17.7%]
Front Med (Lausanne)
The GLORY-1 trial used 4 mg and 6 mg over 48 weeks, while GLORY-2 tested 9 mg over 60 weeks
Mechanism of Action: Tirzepatide integrates the effects of two incretin hormones, GIP and GLP-1, into one molecule, and provides more clinical effects by activating the receptors of these two peptide hormones at the same time
